| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| DVA - DaVita HealthCare Partners Inc | SELL | -25 @ USD 138.17 | USD -3,454 | The ETF sold 25 shares of DVA on 2025-06-11. The shares were previously bought for an average price of USD 154.347. The DaVita HealthCare Partners Inc shares were sold for -10.5% lower than average price of previous purchases. This resulted in an overall loss of USD 404 The average price that the ETF previously sold DVA share for is USD 152.877 which is higher than the selling price of USD 138.17 on 2025-06-11. |
| CRL - Creightons Plc | SELL | -28 @ USD 151.11 | USD -4,231 | The ETF sold 28 shares of CRL on 2025-06-11. The shares were previously bought for an average price of USD 168.232. The Creightons Plc shares were sold for -10.2% lower than average price of previous purchases. This resulted in an overall loss of USD 479 The average price that the ETF previously sold CRL share for is USD 186.601 which is higher than the selling price of USD 151.11 on 2025-06-11. |
| TECH - Bio-Techne Corp | SELL | -87 @ USD 51.54 | USD -4,484 | The ETF sold 87 shares of TECH on 2025-06-11. The shares were previously bought for an average price of USD 65.0058. The Bio-Techne Corp shares were sold for -20.7% lower than average price of previous purchases. This resulted in an overall loss of USD 1,172 The average price that the ETF previously sold TECH share for is USD 69.6136 which is higher than the selling price of USD 51.54 on 2025-06-11. |
| HSIC - Henry Schein Inc | SELL | -69 @ USD 71.14 | USD -4,909 | The ETF sold 69 shares of HSIC on 2025-06-11. The shares were previously bought for an average price of USD 72.8322. The Henry Schein Inc shares were sold for -2.3% lower than average price of previous purchases. This resulted in an overall loss of USD 117 The average price that the ETF previously sold HSIC share for is USD 71.1234 so the ETF has sold 69 shares on 2025-06-11 at a higher price than the previous selling average. |
| MRNA - Moderna Inc | SELL | -184 @ USD 27.75 | USD -5,106 | The ETF sold 184 shares of MRNA on 2025-06-11. The shares were previously bought for an average price of USD 35.3915. The Moderna Inc shares were sold for -21.6% lower than average price of previous purchases. This resulted in an overall loss of USD 1,406 The average price that the ETF previously sold MRNA share for is USD 40.9267 which is higher than the selling price of USD 27.75 on 2025-06-11. |
| UHS - Universal Health Services Inc | SELL | -31 @ USD 172.29 | USD -5,341 | The ETF sold 31 shares of UHS on 2025-06-11. The shares were previously bought for an average price of USD 189.072. The Universal Health Services Inc shares were sold for -8.9% lower than average price of previous purchases. This resulted in an overall loss of USD 520 The average price that the ETF previously sold UHS share for is USD 192.251 which is higher than the selling price of USD 172.29 on 2025-06-11. |
| SOLV - Solventum Corp. | SELL | -74 @ USD 74.41 | USD -5,506 | The ETF sold 74 shares of SOLV on 2025-06-11. The shares were previously bought for an average price of USD 74.1474. The Solventum Corp. shares were sold for 0.4% higher than average price of previous purchases. This sale made a profit of USD 19 The average price that the ETF previously sold SOLV share for is USD 70.4427 so the ETF has sold 74 shares on 2025-06-11 at a higher price than the previous selling average. |
| VTRS - Viatris Inc | SELL | -668 @ USD 8.98 | USD -5,999 | The ETF sold 668 shares of VTRS on 2025-06-11. The shares were previously bought for an average price of USD 10.3985. The Viatris Inc shares were sold for -13.6% lower than average price of previous purchases. This resulted in an overall loss of USD 948 The average price that the ETF previously sold VTRS share for is USD 11.9754 which is higher than the selling price of USD 8.98 on 2025-06-11. |
| INCY - Incyte Corporation | SELL | -89 @ USD 68.85 | USD -6,128 | The ETF sold 89 shares of INCY on 2025-06-11. The shares were previously bought for an average price of USD 69.0067. The Incyte Corporation shares were sold for -0.2% lower than average price of previous purchases. This resulted in an overall loss of USD 14 The average price that the ETF previously sold INCY share for is USD 72.2594 which is higher than the selling price of USD 68.85 on 2025-06-11. |
| RVTY - Revvity Inc. | SELL | -68 @ USD 96.07 | USD -6,533 | The ETF sold 68 shares of RVTY on 2025-06-11. The shares were previously bought for an average price of USD 111.979. The Revvity Inc. shares were sold for -14.2% lower than average price of previous purchases. This resulted in an overall loss of USD 1,082 The average price that the ETF previously sold RVTY share for is USD 112.903 which is higher than the selling price of USD 96.07 on 2025-06-11. |
| ALGN - Align Technology Inc | SELL | -39 @ USD 185.48 | USD -7,234 | The ETF sold 39 shares of ALGN on 2025-06-11. The shares were previously bought for an average price of USD 188.268. The Align Technology Inc shares were sold for -1.5% lower than average price of previous purchases. This resulted in an overall loss of USD 109 The average price that the ETF previously sold ALGN share for is USD 213.562 which is higher than the selling price of USD 185.48 on 2025-06-11. |
| COO - The Cooper Companies, Inc. Common Stock | SELL | -112 @ USD 71.42 | USD -7,999 | The ETF sold 112 shares of COO on 2025-06-11. The shares were previously bought for an average price of USD 89.0886. The The Cooper Companies, Inc. Common Stock shares were sold for -19.8% lower than average price of previous purchases. This resulted in an overall loss of USD 1,979 The average price that the ETF previously sold COO share for is USD 95.053 which is higher than the selling price of USD 71.42 on 2025-06-11. |
| HOLX - Hologic Inc | SELL | -124 @ USD 64.58 | USD -8,008 | The ETF sold 124 shares of HOLX on 2025-06-11. The shares were previously bought for an average price of USD 66.9002. The Hologic Inc shares were sold for -3.5% lower than average price of previous purchases. This resulted in an overall loss of USD 288 The average price that the ETF previously sold HOLX share for is USD 71.719 which is higher than the selling price of USD 64.58 on 2025-06-11. |
| WST - West Pharmaceutical Services Inc | SELL | -39 @ USD 224.01 | USD -8,736 | The ETF sold 39 shares of WST on 2025-06-11. The shares were previously bought for an average price of USD 256.3. The West Pharmaceutical Services Inc shares were sold for -12.6% lower than average price of previous purchases. This resulted in an overall loss of USD 1,259 The average price that the ETF previously sold WST share for is USD 300.204 which is higher than the selling price of USD 224.01 on 2025-06-11. |
| BAX - Baxter International Inc | SELL | -280 @ USD 31.4 | USD -8,792 | The ETF sold 280 shares of BAX on 2025-06-11. The shares were previously bought for an average price of USD 33.3208. The Baxter International Inc shares were sold for -5.8% lower than average price of previous purchases. This resulted in an overall loss of USD 538 The average price that the ETF previously sold BAX share for is USD 32.3642 which is higher than the selling price of USD 31.4 on 2025-06-11. |
| MOH - MOH | SELL | -30 @ USD 294.62 | USD -8,839 | The ETF sold 30 shares of MOH on 2025-06-11. The shares were previously bought for an average price of USD 309.477. The MOH shares were sold for -4.8% lower than average price of previous purchases. This resulted in an overall loss of USD 446 The average price that the ETF previously sold MOH share for is USD 306.548 which is higher than the selling price of USD 294.62 on 2025-06-11. |
| MOH - LVMH Moët Hennessy - Louis Vuitton Société Européenne | SELL | -30 @ USD 294.62 | USD -8,839 | The ETF sold 30 shares of MOH on 2025-06-11. The shares were previously bought for an average price of USD 309.477. The LVMH Moët Hennessy - Louis Vuitton Société Européenne shares were sold for -4.8% lower than average price of previous purchases. This resulted in an overall loss of USD 446 The average price that the ETF previously sold MOH share for is USD 306.548 which is higher than the selling price of USD 294.62 on 2025-06-11. |
| ZBH - Zimmer Biomet Holdings Inc | SELL | -109 @ USD 94.24 | USD -10,272 | The ETF sold 109 shares of ZBH on 2025-06-11. The shares were previously bought for an average price of USD 107.101. The Zimmer Biomet Holdings Inc shares were sold for -12.0% lower than average price of previous purchases. This resulted in an overall loss of USD 1,402 The average price that the ETF previously sold ZBH share for is USD 106.738 which is higher than the selling price of USD 94.24 on 2025-06-11. |
| BIIB - Biogen Inc | SELL | -80 @ USD 133.06 | USD -10,645 | The ETF sold 80 shares of BIIB on 2025-06-11. The shares were previously bought for an average price of USD 145.643. The Biogen Inc shares were sold for -8.6% lower than average price of previous purchases. This resulted in an overall loss of USD 1,007 The average price that the ETF previously sold BIIB share for is USD 156.371 which is higher than the selling price of USD 133.06 on 2025-06-11. |
| DGX - Quest Diagnostics Incorporated | SELL | -62 @ USD 176.98 | USD -10,973 | The ETF sold 62 shares of DGX on 2025-06-11. The shares were previously bought for an average price of USD 167.015. The Quest Diagnostics Incorporated shares were sold for 6.0% higher than average price of previous purchases. This sale made a profit of USD 618 The average price that the ETF previously sold DGX share for is USD 160.379 so the ETF has sold 62 shares on 2025-06-11 at a higher price than the previous selling average. |
| WAT - Waters Corporation | SELL | -32 @ USD 346.05 | USD -11,074 | The ETF sold 32 shares of WAT on 2025-06-11. The shares were previously bought for an average price of USD 369.261. The Waters Corporation shares were sold for -6.3% lower than average price of previous purchases. This resulted in an overall loss of USD 743 The average price that the ETF previously sold WAT share for is USD 371.334 which is higher than the selling price of USD 346.05 on 2025-06-11. |
| WAT - MULETFWATIMETFP | SELL | -32 @ USD 346.05 | USD -11,074 | The ETF sold 32 shares of WAT on 2025-06-11. The shares were previously bought for an average price of USD 369.261. The MULETFWATIMETFP shares were sold for -6.3% lower than average price of previous purchases. This resulted in an overall loss of USD 743 The average price that the ETF previously sold WAT share for is USD 371.334 which is higher than the selling price of USD 346.05 on 2025-06-11. |
| PODD - Insulet Corporation | SELL | -38 @ USD 302.24 | USD -11,485 | The ETF sold 38 shares of PODD on 2025-06-11. The shares were previously bought for an average price of USD 268.184. The Insulet Corporation shares were sold for 12.7% higher than average price of previous purchases. This sale made a profit of USD 1,294 The average price that the ETF previously sold PODD share for is USD 265.171 so the ETF has sold 38 shares on 2025-06-11 at a higher price than the previous selling average. |
| LH - Laboratory Corporation of America Holdings | SELL | -45 @ USD 259.95 | USD -11,698 | The ETF sold 45 shares of LH on 2025-06-11. The shares were previously bought for an average price of USD 241.284. The Laboratory Corporation of America Holdings shares were sold for 7.7% higher than average price of previous purchases. This sale made a profit of USD 840 The average price that the ETF previously sold LH share for is USD 236.811 so the ETF has sold 45 shares on 2025-06-11 at a higher price than the previous selling average. |
| MTD - Mettler-Toledo International Inc | SELL | -11 @ USD 1192.98 | USD -13,123 | The ETF sold 11 shares of MTD on 2025-06-11. The shares were previously bought for an average price of USD 1239.38. The Mettler-Toledo International Inc shares were sold for -3.7% lower than average price of previous purchases. This resulted in an overall loss of USD 510 The average price that the ETF previously sold MTD share for is USD 1236.18 which is higher than the selling price of USD 1192.98 on 2025-06-11. |
| MTD - AMUNDI EUR GOV 710 | SELL | -11 @ USD 1192.98 | USD -13,123 | The ETF sold 11 shares of MTD on 2025-06-11. The shares were previously bought for an average price of USD 1239.38. The AMUNDI EUR GOV 710 shares were sold for -3.7% lower than average price of previous purchases. This resulted in an overall loss of USD 510 The average price that the ETF previously sold MTD share for is USD 1236.18 which is higher than the selling price of USD 1192.98 on 2025-06-11. |
| STE - STERIS plc | SELL | -55 @ USD 240.74 | USD -13,241 | The ETF sold 55 shares of STE on 2025-06-11. The shares were previously bought for an average price of USD 222.089. The STERIS plc shares were sold for 8.4% higher than average price of previous purchases. This sale made a profit of USD 1,026 The average price that the ETF previously sold STE share for is USD 216.826 so the ETF has sold 55 shares on 2025-06-11 at a higher price than the previous selling average. |
| IQV - IQVIA Holdings Inc | SELL | -92 @ USD 158.83 | USD -14,612 | The ETF sold 92 shares of IQV on 2025-06-11. The shares were previously bought for an average price of USD 191.616. The IQVIA Holdings Inc shares were sold for -17.1% lower than average price of previous purchases. This resulted in an overall loss of USD 3,016 The average price that the ETF previously sold IQV share for is USD 195.113 which is higher than the selling price of USD 158.83 on 2025-06-11. |
| CNC - Concurrent Technologies Plc | SELL | -276 @ USD 55.27 | USD -15,255 | The ETF sold 276 shares of CNC on 2025-06-11. The shares were previously bought for an average price of USD 60.1182. The Concurrent Technologies Plc shares were sold for -8.1% lower than average price of previous purchases. This resulted in an overall loss of USD 1,338 The average price that the ETF previously sold CNC share for is USD 59.9852 which is higher than the selling price of USD 55.27 on 2025-06-11. |
| HUM - Hummingbird Resources PLC | SELL | -66 @ USD 231.74 | USD -15,295 | The ETF sold 66 shares of HUM on 2025-06-11. The shares were previously bought for an average price of USD 270.038. The Hummingbird Resources PLC shares were sold for -14.2% lower than average price of previous purchases. This resulted in an overall loss of USD 2,528 The average price that the ETF previously sold HUM share for is USD 275.192 which is higher than the selling price of USD 231.74 on 2025-06-11. |
| HUM - Humana Inc | SELL | -66 @ USD 231.74 | USD -15,295 | The ETF sold 66 shares of HUM on 2025-06-11. The shares were previously bought for an average price of USD 270.038. The Humana Inc shares were sold for -14.2% lower than average price of previous purchases. This resulted in an overall loss of USD 2,528 The average price that the ETF previously sold HUM share for is USD 275.192 which is higher than the selling price of USD 231.74 on 2025-06-11. |
| DXCM - DexCom Inc | SELL | -217 @ USD 82.99 | USD -18,009 | The ETF sold 217 shares of DXCM on 2025-06-11. The shares were previously bought for an average price of USD 77.8843. The DexCom Inc shares were sold for 6.6% higher than average price of previous purchases. This sale made a profit of USD 1,108 The average price that the ETF previously sold DXCM share for is USD 76.0472 so the ETF has sold 217 shares on 2025-06-11 at a higher price than the previous selling average. |
| GEHC - GE HealthCare Technologies Inc. | SELL | -251 @ USD 73.4 | USD -18,423 | The ETF sold 251 shares of GEHC on 2025-06-11. The shares were previously bought for an average price of USD 84.8343. The GE HealthCare Technologies Inc. shares were sold for -13.5% lower than average price of previous purchases. This resulted in an overall loss of USD 2,870 The average price that the ETF previously sold GEHC share for is USD 80.7559 which is higher than the selling price of USD 73.4 on 2025-06-11. |
| A - Agilent Technologies Inc | SELL | -157 @ USD 119.72 | USD -18,796 | The ETF sold 157 shares of A on 2025-06-11. The shares were previously bought for an average price of USD 128.911. The Agilent Technologies Inc shares were sold for -7.1% lower than average price of previous purchases. This resulted in an overall loss of USD 1,443 The average price that the ETF previously sold A share for is USD 131.719 which is higher than the selling price of USD 119.72 on 2025-06-11. |
| RMD - ResMed Inc | SELL | -81 @ USD 251.36 | USD -20,360 | The ETF sold 81 shares of RMD on 2025-06-11. The shares were previously bought for an average price of USD 234.22. The ResMed Inc shares were sold for 7.3% higher than average price of previous purchases. This sale made a profit of USD 1,388 The average price that the ETF previously sold RMD share for is USD 240.511 so the ETF has sold 81 shares on 2025-06-11 at a higher price than the previous selling average. |
| CAH - Cardinal Health Inc | SELL | -134 @ USD 153.53 | USD -20,573 | The ETF sold 134 shares of CAH on 2025-06-11. The shares were previously bought for an average price of USD 128.331. The Cardinal Health Inc shares were sold for 19.6% higher than average price of previous purchases. This sale made a profit of USD 3,377 The average price that the ETF previously sold CAH share for is USD 123.961 so the ETF has sold 134 shares on 2025-06-11 at a higher price than the previous selling average. |
| IDXX - IDEXX Laboratories Inc | SELL | -44 @ USD 524.18 | USD -23,064 | The ETF sold 44 shares of IDXX on 2025-06-11. The shares were previously bought for an average price of USD 440.802. The IDEXX Laboratories Inc shares were sold for 18.9% higher than average price of previous purchases. This sale made a profit of USD 3,669 The average price that the ETF previously sold IDXX share for is USD 431.817 so the ETF has sold 44 shares on 2025-06-11 at a higher price than the previous selling average. |
| EW - Edwards Lifesciences Corp | SELL | -326 @ USD 75.47 | USD -24,603 | The ETF sold 326 shares of EW on 2025-06-11. The shares were previously bought for an average price of USD 71.2794. The Edwards Lifesciences Corp shares were sold for 5.9% higher than average price of previous purchases. This sale made a profit of USD 1,366 The average price that the ETF previously sold EW share for is USD 70.6166 so the ETF has sold 326 shares on 2025-06-11 at a higher price than the previous selling average. |
| COR - Cencora Inc. | SELL | -95 @ USD 286.64 | USD -27,231 | The ETF sold 95 shares of COR on 2025-06-11. The shares were previously bought for an average price of USD 254.646. The Cencora Inc. shares were sold for 12.6% higher than average price of previous purchases. This sale made a profit of USD 3,039 The average price that the ETF previously sold COR share for is USD 248.192 so the ETF has sold 95 shares on 2025-06-11 at a higher price than the previous selling average. |
| BDX - Becton Dickinson and Company | SELL | -159 @ USD 172.72 | USD -27,462 | The ETF sold 159 shares of BDX on 2025-06-11. The shares were previously bought for an average price of USD 226.588. The Becton Dickinson and Company shares were sold for -23.8% lower than average price of previous purchases. This resulted in an overall loss of USD 8,565 The average price that the ETF previously sold BDX share for is USD 221.171 which is higher than the selling price of USD 172.72 on 2025-06-11. |
| REGN - Regeneron Pharmaceuticals Inc | SELL | -58 @ USD 518.6 | USD -30,079 | The ETF sold 58 shares of REGN on 2025-06-11. The shares were previously bought for an average price of USD 704.506. The Regeneron Pharmaceuticals Inc shares were sold for -26.4% lower than average price of previous purchases. This resulted in an overall loss of USD 10,783 The average price that the ETF previously sold REGN share for is USD 739.691 which is higher than the selling price of USD 518.6 on 2025-06-11. |
| HCA - HCA Holdings Inc | SELL | -98 @ USD 367.59 | USD -36,024 | The ETF sold 98 shares of HCA on 2025-06-11. The shares were previously bought for an average price of USD 337.989. The HCA Holdings Inc shares were sold for 8.8% higher than average price of previous purchases. This sale made a profit of USD 2,901 The average price that the ETF previously sold HCA share for is USD 329.244 so the ETF has sold 98 shares on 2025-06-11 at a higher price than the previous selling average. |
| ZTS - Zoetis Inc | SELL | -247 @ USD 166.33 | USD -41,084 | The ETF sold 247 shares of ZTS on 2025-06-11. The shares were previously bought for an average price of USD 167.219. The Zoetis Inc shares were sold for -0.5% lower than average price of previous purchases. This resulted in an overall loss of USD 220 The average price that the ETF previously sold ZTS share for is USD 171.212 which is higher than the selling price of USD 166.33 on 2025-06-11. |
| CI - Cigna Corp | SELL | -150 @ USD 310.2 | USD -46,530 | The ETF sold 150 shares of CI on 2025-06-11. The shares were previously bought for an average price of USD 316.767. The Cigna Corp shares were sold for -2.1% lower than average price of previous purchases. This resulted in an overall loss of USD 985 The average price that the ETF previously sold CI share for is USD 312.869 which is higher than the selling price of USD 310.2 on 2025-06-11. |
| ELV - Elevance Health Inc | SELL | -127 @ USD 380.93 | USD -48,378 | The ETF sold 127 shares of ELV on 2025-06-11. The shares were previously bought for an average price of USD 410.75. The Elevance Health Inc shares were sold for -7.3% lower than average price of previous purchases. This resulted in an overall loss of USD 3,787 The average price that the ETF previously sold ELV share for is USD 401.478 which is higher than the selling price of USD 380.93 on 2025-06-11. |
| ELV - Elevance Health Inc | SELL | -127 @ USD 380.93 | USD -48,378 | The ETF sold 127 shares of ELV on 2025-06-11. The shares were previously bought for an average price of USD 410.75. The Elevance Health Inc shares were sold for -7.3% lower than average price of previous purchases. This resulted in an overall loss of USD 3,787 The average price that the ETF previously sold ELV share for is USD 401.478 which is higher than the selling price of USD 380.93 on 2025-06-11. |
| MCK - McKesson Corporation | SELL | -69 @ USD 717.76 | USD -49,525 | The ETF sold 69 shares of MCK on 2025-06-11. The shares were previously bought for an average price of USD 621.578. The McKesson Corporation shares were sold for 15.5% higher than average price of previous purchases. This sale made a profit of USD 6,637 The average price that the ETF previously sold MCK share for is USD 607.031 so the ETF has sold 69 shares on 2025-06-11 at a higher price than the previous selling average. |
| BMY - Bloomsbury Publishing Plc | SELL | -1,122 @ USD 50.16 | USD -56,280 | The ETF sold 1122 shares of BMY on 2025-06-11. The shares were previously bought for an average price of USD 57.3147. The Bloomsbury Publishing Plc shares were sold for -12.5% lower than average price of previous purchases. This resulted in an overall loss of USD 8,028 The average price that the ETF previously sold BMY share for is USD 56.0694 which is higher than the selling price of USD 50.16 on 2025-06-11. |
| MDT - Medtronic PLC | SELL | -708 @ USD 88.06 | USD -62,346 | The ETF sold 708 shares of MDT on 2025-06-11. The shares were previously bought for an average price of USD 88.7467. The Medtronic PLC shares were sold for -0.8% lower than average price of previous purchases. This resulted in an overall loss of USD 486 The average price that the ETF previously sold MDT share for is USD 85.4514 so the ETF has sold 708 shares on 2025-06-11 at a higher price than the previous selling average. |
| VRTX - Vertex Pharmaceuticals Inc | SELL | -141 @ USD 452.44 | USD -63,794 | The ETF sold 141 shares of VRTX on 2025-06-11. The shares were previously bought for an average price of USD 478.652. The Vertex Pharmaceuticals Inc shares were sold for -5.5% lower than average price of previous purchases. This resulted in an overall loss of USD 3,696 The average price that the ETF previously sold VRTX share for is USD 462.774 which is higher than the selling price of USD 452.44 on 2025-06-11. |
| SYK - Stryker Corporation | SELL | -189 @ USD 381.08 | USD -72,024 | The ETF sold 189 shares of SYK on 2025-06-11. The shares were previously bought for an average price of USD 379.729. The Stryker Corporation shares were sold for 0.4% higher than average price of previous purchases. This sale made a profit of USD 255 The average price that the ETF previously sold SYK share for is USD 375.395 so the ETF has sold 189 shares on 2025-06-11 at a higher price than the previous selling average. |
| DHR - Danaher Corporation | SELL | -353 @ USD 204.72 | USD -72,266 | The ETF sold 353 shares of DHR on 2025-06-11. The shares were previously bought for an average price of USD 216.682. The Danaher Corporation shares were sold for -5.5% lower than average price of previous purchases. This resulted in an overall loss of USD 4,223 The average price that the ETF previously sold DHR share for is USD 229.627 which is higher than the selling price of USD 204.72 on 2025-06-11. |
| DHR - Danaher Corporation | SELL | -353 @ USD 204.72 | USD -72,266 | The ETF sold 353 shares of DHR on 2025-06-11. The shares were previously bought for an average price of USD 216.682. The Danaher Corporation shares were sold for -5.5% lower than average price of previous purchases. This resulted in an overall loss of USD 4,223 The average price that the ETF previously sold DHR share for is USD 229.627 which is higher than the selling price of USD 204.72 on 2025-06-11. |
| GILD - Guild Esports Plc | SELL | -689 @ USD 109.3 | USD -75,308 | The ETF sold 689 shares of GILD on 2025-06-11. The shares were previously bought for an average price of USD 102.991. The Guild Esports Plc shares were sold for 6.1% higher than average price of previous purchases. This sale made a profit of USD 4,347 The average price that the ETF previously sold GILD share for is USD 95.1611 so the ETF has sold 689 shares on 2025-06-11 at a higher price than the previous selling average. |
| PFE - Pfizer Inc | SELL | -3,133 @ USD 24.48 | USD -76,696 | The ETF sold 3133 shares of PFE on 2025-06-11. The shares were previously bought for an average price of USD 25.8066. The Pfizer Inc shares were sold for -5.1% lower than average price of previous purchases. This resulted in an overall loss of USD 4,156 The average price that the ETF previously sold PFE share for is USD 25.8159 which is higher than the selling price of USD 24.48 on 2025-06-11. |
| BSX - Boston Scientific Corporation | SELL | -814 @ USD 99.4 | USD -80,912 | The ETF sold 814 shares of BSX on 2025-06-11. The shares were previously bought for an average price of USD 98.6851. The Boston Scientific Corporation shares were sold for 0.7% higher than average price of previous purchases. This sale made a profit of USD 582 The average price that the ETF previously sold BSX share for is USD 91.0981 so the ETF has sold 814 shares on 2025-06-11 at a higher price than the previous selling average. |
| BSX - MULSTRXSSXIMETFP | SELL | -814 @ USD 99.4 | USD -80,912 | The ETF sold 814 shares of BSX on 2025-06-11. The shares were previously bought for an average price of USD 98.6851. The MULSTRXSSXIMETFP shares were sold for 0.7% higher than average price of previous purchases. This sale made a profit of USD 582 The average price that the ETF previously sold BSX share for is USD 91.0981 so the ETF has sold 814 shares on 2025-06-11 at a higher price than the previous selling average. |
| AMGN - Amgen Inc | SELL | -296 @ USD 291.81 | USD -86,376 | The ETF sold 296 shares of AMGN on 2025-06-11. The shares were previously bought for an average price of USD 303.22. The Amgen Inc shares were sold for -3.8% lower than average price of previous purchases. This resulted in an overall loss of USD 3,377 The average price that the ETF previously sold AMGN share for is USD 288.87 so the ETF has sold 296 shares on 2025-06-11 at a higher price than the previous selling average. |
| TMO - Time Out Group plc | SELL | -211 @ USD 415.15 | USD -87,597 | The ETF sold 211 shares of TMO on 2025-06-11. The shares were previously bought for an average price of USD 521.751. The Time Out Group plc shares were sold for -20.4% lower than average price of previous purchases. This resulted in an overall loss of USD 22,493 The average price that the ETF previously sold TMO share for is USD 516.174 which is higher than the selling price of USD 415.15 on 2025-06-11. |
| ISRG - Intuitive Surgical Inc | SELL | -196 @ USD 522.41 | USD -102,392 | The ETF sold 196 shares of ISRG on 2025-06-11. The shares were previously bought for an average price of USD 541.1. The Intuitive Surgical Inc shares were sold for -3.5% lower than average price of previous purchases. This resulted in an overall loss of USD 3,663 The average price that the ETF previously sold ISRG share for is USD 531.221 which is higher than the selling price of USD 522.41 on 2025-06-11. |
| MRK - Marks Electrical Group PLC | SELL | -1,399 @ USD 80.32 | USD -112,368 | The ETF sold 1399 shares of MRK on 2025-06-11. The shares were previously bought for an average price of USD 91.8712. The Marks Electrical Group PLC shares were sold for -12.6% lower than average price of previous purchases. This resulted in an overall loss of USD 16,160 The average price that the ETF previously sold MRK share for is USD 97.5851 which is higher than the selling price of USD 80.32 on 2025-06-11. |
| MRK - Merck & Company Inc | SELL | -1,399 @ USD 80.32 | USD -112,368 | The ETF sold 1399 shares of MRK on 2025-06-11. The shares were previously bought for an average price of USD 91.8712. The Merck & Company Inc shares were sold for -12.6% lower than average price of previous purchases. This resulted in an overall loss of USD 16,160 The average price that the ETF previously sold MRK share for is USD 97.5851 which is higher than the selling price of USD 80.32 on 2025-06-11. |
| ABT - Abbott Laboratories | SELL | -959 @ USD 135.28 | USD -129,734 | The ETF sold 959 shares of ABT on 2025-06-11. The shares were previously bought for an average price of USD 127.034. The Abbott Laboratories shares were sold for 6.5% higher than average price of previous purchases. This sale made a profit of USD 7,908 The average price that the ETF previously sold ABT share for is USD 118.57 so the ETF has sold 959 shares on 2025-06-11 at a higher price than the previous selling average. |
| UNH - UnitedHealth Group Incorporated | SELL | -507 @ USD 310.56 | USD -157,454 | The ETF sold 507 shares of UNH on 2025-06-11. The shares were previously bought for an average price of USD 524.136. The UnitedHealth Group Incorporated shares were sold for -40.7% lower than average price of previous purchases. This resulted in an overall loss of USD 108,283 The average price that the ETF previously sold UNH share for is USD 543.887 which is higher than the selling price of USD 310.56 on 2025-06-11. |
| ABBV - AbbVie Inc | SELL | -971 @ USD 191.5 | USD -185,947 | The ETF sold 971 shares of ABBV on 2025-06-11. The shares were previously bought for an average price of USD 193.556. The AbbVie Inc shares were sold for -1.1% lower than average price of previous purchases. This resulted in an overall loss of USD 1,996 The average price that the ETF previously sold ABBV share for is USD 185.153 so the ETF has sold 971 shares on 2025-06-11 at a higher price than the previous selling average. |
| JNJ - Johnson & Johnson | SELL | -1,323 @ USD 155.26 | USD -205,409 | The ETF sold 1323 shares of JNJ on 2025-06-11. The shares were previously bought for an average price of USD 157.979. The Johnson & Johnson shares were sold for -1.7% lower than average price of previous purchases. This resulted in an overall loss of USD 3,597 The average price that the ETF previously sold JNJ share for is USD 152.666 so the ETF has sold 1323 shares on 2025-06-11 at a higher price than the previous selling average. |
| CVS - CVS Health Corp | SELL | -4,078 @ USD 65.72 | USD -268,006 | The ETF sold 4078 shares of CVS on 2025-06-11. The shares were previously bought for an average price of USD 62.9223. The CVS Health Corp shares were sold for 4.4% higher than average price of previous purchases. This sale made a profit of USD 11,409 The average price that the ETF previously sold CVS share for is USD 55.5173 so the ETF has sold 4078 shares on 2025-06-11 at a higher price than the previous selling average. |
| LLY - Eli Lilly and Company | SELL | -430 @ USD 808.61 | USD -347,702 | The ETF sold 430 shares of LLY on 2025-06-11. The shares were previously bought for an average price of USD 837.646. The Eli Lilly and Company shares were sold for -3.5% lower than average price of previous purchases. This resulted in an overall loss of USD 12,485 The average price that the ETF previously sold LLY share for is USD 793.005 so the ETF has sold 430 shares on 2025-06-11 at a higher price than the previous selling average. |